IMMUNOHISTOCHEMICAL DETECTION OF CEA AND CA 15-3 IN BREAST-CANCER - RELATION TO SERUM LEVELS AND PROGNOSTIC FACTORS

被引：0
|
作者：
WEIKEL, W
KLEINMANN, A
BECK, T
MITZE, M
MOBUS, V
KREIENBERG, R
机构：
来源：
TUMORDIAGNOSTIK & THERAPIE | 1992年 / 13卷 / 05期
关键词：
BREAST CANCER; IMMUNOHISTOCHEMISTRY; TUMOR MARKER; CEA-CA-15-3;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In human breast cancer immunohistochemical detection of CEA and CA 15-3 was compared to the serum levels to these antigens. A significant correlation between immunohistochemical and serological positivity was found in 155 cases of CEA determination. In 159 cases of CA 15-3 analysis, a significant correlation between negative immunohistochemistry and positive serologic detection and vice versa was obtained. Concerning CEA, no correlation was found for immunohistochemical as well as serological analysis between stage of disease, lymphatic node involvement, histological grading, histological typing, immunohistochemical and biochemical hormone receptor assay., growth fraction (Ki-67), and NEU-protein overexpression. A clinical not significant trend was found towards better prognosis of serologically positive cases with respect to survival period and recurrence free interval. Concerning CA 15-3, in the same way no correlation was found with the mentioned prognostic factors except for a correlation of serum levels with the tumor mass. Patients with positive immunohistochemical or negative serological expression of CA 15-3 indicated a not significant trend towards better prognosis.
引用
收藏
页码：178 / 186
页数：9
相关论文
共 50 条
  • [21] Serum levels of CEA and CA 15-3 in triple-negative breast cancer at the time of diagnosis
    Didem S. Dede
    Cagatay Arslan
    Kadri Altundag
    Medical Oncology, 2010, 27 : 1429 - 1429
  • [22] Serum levels of CEA and CA 15-3 in triple-negative breast cancer at the time of diagnosis
    Dede, Didem S.
    Arslan, Cagatay
    Altundag, Kadri
    MEDICAL ONCOLOGY, 2010, 27 (04) : 1429 - 1429
  • [23] Clinical significance of CA 15-3 and CEA in detection of breast cancer recurrence
    Mok, C. W.
    Lim, S. K.
    Seah, J.
    Kam, J. W.
    Tan, S. M.
    BREAST, 2015, 24 : S107 - S108
  • [24] CEA, CA 15-3, AND MCA IN THE FOLLOW-UP OF BREAST-CANCER PATIENTS
    GIUDICI, S
    REPETTO, L
    NASO, C
    MERLINI, L
    SIMONI, C
    GARDI, G
    ONETTO, M
    CAMPORA, E
    ROSSO, R
    CANCER DETECTION AND PREVENTION, 1993, 17 (02): : 341 - 341
  • [25] SENSITIVITY AND SPECIFICITY OF CEA, CA 15-3 AND MCA IN VISCERAL METASTASIS OF BREAST-CANCER
    DELBRUCK, H
    HAGENAUKAMP, C
    BRAUN, G
    STRAHLENTHERAPIE UND ONKOLOGIE, 1990, 166 (07): : 457 - 459
  • [26] Sensitivity of CA 15-3, CEA and serum HER2 in the early detection of recurrence of breast cancer
    Pedersen, Ann Christina
    Sorensen, Patricia Diana
    Jacobsen, Erik Hugger
    Madsen, Jonna Skov
    Brandslund, Ivan
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2013, 51 (07) : 1511 - 1519
  • [27] CEA and early detection of relapse in breast cancer subtypes: Comparison with CA 15-3
    Riedinger, Jean-Marc
    Goussot, Vincent
    Desmoulins, Isabelle
    Lorgis, Veronique
    Coutant, Charles
    Beltjens, Francoise
    Lizard, Sarab
    Fumoleau, Pierre
    BULLETIN DU CANCER, 2016, 103 (05) : 434 - 443
  • [28] CA 15-3: a prognostic marker in breast cancer
    Duffy, MJ
    Shering, S
    Sherry, F
    McDermott, E
    O'Higgins, N
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2000, 15 (04): : 330 - 333
  • [29] PROGNOSTIC-IMPACT OF CA-15-3 AND CEA IN BREAST-CANCER
    WAFFLART, J
    ANGIBEAU, RM
    BONICHON, F
    AVRIL, A
    MAGE, P
    MAREE, D
    MAURIAC, L
    DURAND, M
    BULLETIN DU CANCER, 1987, 74 (06) : 685 - 685
  • [30] Pretreatment values of serum CA 15-3 antigen related to prognostic factors in breast cancer patients
    Wojtacki, J
    DziewulskaBokiniec, A
    Kowalski, DM
    Zoltowska, A
    Ciesielski, D
    Suszko, M
    NEOPLASMA, 1996, 43 (04) : 225 - 229
12345